Alan H. Auerbach - Los Angeles Business Journal
Robbins Geller Rudman & Dowd LLP Announces Plaintiff's Verdict in Securities Class Action Trial Against Puma Biotechnology, Inc. and Its Ceo, Alan H. Auerbach
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Securities Group Of The Year: Robbins Geller
Puma Back Up on FDA OK - Los Angeles Business Journal
Alan H. Auerbach - CEO, President & Chairman at Puma Biotechnology | The Org
Puma Biotechnology Culture | Comparably
Highest-Paid Chiefs in 2014 - The New York Times
PUMA BIOTECHNOLOGY, INC. FORM 8-K/A - Shareholder.com
Puma Biotechnology - Contacts, Employees, Board Members, Advisors & Alumni
Alan AUERBACH | CEO | Puma Biotechnology, Inc, California | Corporate | Research profile
PBYI: Puma Biotechnology Inc Stock Price Quote - NASDAQ GS - Bloomberg
Puma Biotechnology - Overview, News & Competitors | ZoomInfo.com
Alan Auerbach email address & phone number | Puma Biotechnology, Inc Chief Executive Officer, President contact information - RocketReach
Alan H. Auerbach - Chief Executive Officer & President @ Puma Biotechnology - Crunchbase Person Profile
Puma Biotechnology Announces $10 Million Private Placement | Business Wire
Biotech Entrepreneur's Fortune Nearly Doubles After Strong Clinical Trials For Cancer Treatment
Alan H. Auerbach Net Worth (2023) | wallmine
Puma Biotechnology Executive Salaries | Comparably
Local Executive Pay Experiences Recovery - Los Angeles Business Journal
A Top Puma Bio Exec Resigns Ahead of FDA Panel, Analysts Defend With Conflicting Stories - TheStreet
Puma Biotech victory in neratinib litigation
